Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 16Pancreatic Neoplasms 9Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Carcinoma, Renal Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Melanoma 5Ovarian Neoplasms 4Neoplasm Metastasis 4Carcinoma, Merkel Cell 4Turcot syndrome 3Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Head and Neck Neoplasms 3Colonic Neoplasms 3Carcinoma, Transitional Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Microsatellite Instability 2Gastrointestinal Neoplasms 2Sarcoma 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Cancer Resectable 1Mesothelioma, Malignant 1Liver Diseases 1

Interventions

Sorafenib 5lenvatinib 3sintilimab 2pembrolizumab 2halofantrine 2camrelizumab 2atezolizumab 2Immunotherapy 2Blood Specimen Collection 2Bevacizumab 2Antibodies 2trifluridine tipiracil drug combination 1trametinib 1toripalimab 1titanium silicide 1tislelizumab 1linifanib 1genexol-PM 1gadolinium ethoxybenzyl DTPA 1fluorocholine 1fisogatinib 1ficlatuzumab 1durvalumab 1bavituximab 1avelumab 1User-Centered Design 1Sunitinib 1Sufentanil 1Standard of Care 1Shadowing Technique, Histology 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liver Diseases × avelumab × Gastrointestinal × Clear all
NCT03289533 2020-09-04

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Pfizer

Phase 1 Completed
22 enrolled 25 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡